Yaneicy Gonzalez Rojas
Internal Medicine · Coral Gables, FLNPI 1639300304
Payments from drug & device makers
Across 5,400 payments — averaging $17,322 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$24.4M
- Eisai Inc.$20.7M
- Pfizer$10.6M
- Genentech, Inc.$6.9M
- Boehringer Ingelheim$5.8M
- Boehringer Ingelheim International GmbH$5.7M
- plus $19.5M from 25 others
Across 15 payments — averaging $33,254 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$469K
- Vifor (international) Ltd.$30K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$175
- Novo Nordisk AS$121
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$93,538,807 in reported general payments places this provider in the 95th percentile of 8,530 internal medicine providers in Florida.
Other internal medicine in Coral Gables
- Jeffrey RosenCoral Gables$17M
- Carlos IglesiasCoral Gables$6.6M
- Juan Carlos RondonHollywood$66.8M
- Jaynier MoyaPembroke Pines$45.4M
- Mark KutnerMiami$35.7M
- Gilberto JimenezHialeah$35.6M
- Mira BaronWest Palm Beach$29.6M
- William SanchezHialeah$28.9M
- Nelia Sanchez-CrespoHollywood$28.8M
- Kwabena AyesuOrlando$27.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.